429 related articles for article (PubMed ID: 8595961)
1. Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.
Rabiah PK; Fiscella RG; Tessler HH
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):613-8. PubMed ID: 8595961
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.
Barañano DE; Kim SJ; Edelhauser HF; Durairaj C; Kompella UB; Handa JT
Br J Ophthalmol; 2009 Oct; 93(10):1387-90. PubMed ID: 19628498
[TBL] [Abstract][Full Text] [Related]
3. [Antiinflammatory capacity of topical ketorolac in experimental model of ocular inflammation].
Moreno OR; Andrés RC; Júlvez LP; Llorens VP; Marín Del Tiempo D; Novella EF; Torrón C; Honrubia FM
Arch Soc Esp Oftalmol; 2000; 75(5):333-8. PubMed ID: 11151171
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
5. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.
Malhotra M; Majumdar DK
Indian J Exp Biol; 1997 Sep; 35(9):941-7. PubMed ID: 9475074
[TBL] [Abstract][Full Text] [Related]
6. [Study of topical ketorolac effect on arachidonic acid metabolism in experimental anterior uveitis].
Cuevas Andrés R ; Ruiz Moreno O ; Ferrer Novella E ; Torrón Fernández-Blanco C ; Rojo Aragües A ; Pablo Júlvez LE ; Honrubia López FM
Arch Soc Esp Oftalmol; 2000 Jul; 75(7):443-8. PubMed ID: 11151195
[TBL] [Abstract][Full Text] [Related]
7. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
[TBL] [Abstract][Full Text] [Related]
8. Ketorolac, an injectable nonnarcotic analgesic.
Litvak KM; McEvoy GK
Clin Pharm; 1990 Dec; 9(12):921-35. PubMed ID: 2292174
[TBL] [Abstract][Full Text] [Related]
9. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
Simone JN; Pendelton RA; Jenkins JE
J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
[TBL] [Abstract][Full Text] [Related]
12. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
[TBL] [Abstract][Full Text] [Related]
13. Ketorolac tromethamine.
Med Lett Drugs Ther; 1990 Aug; 32(825):79-81. PubMed ID: 2199809
[No Abstract] [Full Text] [Related]
14. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
Stewart R; Grosserode R; Cheetham JK; Rosenthal A
Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
[TBL] [Abstract][Full Text] [Related]
15. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone.
Flach AJ; Jaffe NS; Akers WA
Ann Ophthalmol; 1989 Nov; 21(11):407-11. PubMed ID: 2619149
[TBL] [Abstract][Full Text] [Related]
16. Ketorolac and patient controlled analgesia in the treatment of postoperative pain.
Cataldo PA; Senagore AJ; Kilbride MJ
Surg Gynecol Obstet; 1993 May; 176(5):435-8. PubMed ID: 8480264
[TBL] [Abstract][Full Text] [Related]
17. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Bucci FA; Waterbury LD
Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
[TBL] [Abstract][Full Text] [Related]
18. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
[TBL] [Abstract][Full Text] [Related]
19. The difficulty of determining the route of intraocular penetration of gentamicin after subconjunctival injection in the rabbit.
Barza M; Kane A; Baum J
Invest Ophthalmol Vis Sci; 1981 Apr; 20(4):509-14. PubMed ID: 7216668
[TBL] [Abstract][Full Text] [Related]
20. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
